The way to deliver antigens and cellular requirements for long-lasting protection against tuberculosis are not known. Immunizations with mycobacterial 65 kDa heat shock protein (hsp65) expressed from J774-hsp65 cells (antigen-presenting cells that endogenously produce hsp65 antigen) or from plasmid DNA, or with the protein entrapped in cationic liposomes. can each give protective immunity similar to that obtained from live Bacillus Calmette Guerin (BCG), whereas injecting the protein in Freund's incomplete adjuvant (FIA) has minimal effect. Protective procedures elicited high frequencies of antigen-reactive rp T cells with CD4(+)/CD8(-) and CD8(+)/CD4(-) phenotypes. Protection correlated with the abundance of hsp65-dependent cytotoxic CD8(+...
Tuberculosis (TB) is a major health problem of global concern. The control of this disease requires ...
H65, a fusion protein of three pairs of ESX-secreted antigens of Mycobacterium tuberculosis and Myco...
In previous studies, we have described a live recombinant BCG vaccine (rBCG30) overexpressing the 30...
Tuberculosis is a major threat to human health. The high disease burden remains unaffected and the a...
The great challenges for researchers working in the field of vaccinology are optimizing DNA vaccines...
CD4(+) Foxp3(+) regulatory T cells inhibit the production of interferon-?, which is the major mediat...
Of the hundreds of new tuberculosis ( TB) vaccine candidates some have therapeutic value in addition...
To test the relative efficacy of CD4 and CD8T cells in mediating protective immunity to Mycobacteriu...
Background : Priming and boosting vaccination strategy has been widely explored for new vaccine deve...
The anti-tuberculosis vaccine, Mycobacterium bovis BCG, has been used worldwide, but its protective ...
The memory/activated T cells, which mediate the long-lived host response against tuberculosis, in mi...
DNA vaccine may be a promising tool for controlling tuberculosis development. However, vaccines enco...
Mycobacteria can infect macrophages and dendritic cells (DC), where they reside inside the endosomal...
AbstractTo test the relative efficacy of CD4 and CD8T cells in mediating protective immunity to Myco...
Background. Studies of different vaccine constructs have demonstrated variable efficacy against Myco...
Tuberculosis (TB) is a major health problem of global concern. The control of this disease requires ...
H65, a fusion protein of three pairs of ESX-secreted antigens of Mycobacterium tuberculosis and Myco...
In previous studies, we have described a live recombinant BCG vaccine (rBCG30) overexpressing the 30...
Tuberculosis is a major threat to human health. The high disease burden remains unaffected and the a...
The great challenges for researchers working in the field of vaccinology are optimizing DNA vaccines...
CD4(+) Foxp3(+) regulatory T cells inhibit the production of interferon-?, which is the major mediat...
Of the hundreds of new tuberculosis ( TB) vaccine candidates some have therapeutic value in addition...
To test the relative efficacy of CD4 and CD8T cells in mediating protective immunity to Mycobacteriu...
Background : Priming and boosting vaccination strategy has been widely explored for new vaccine deve...
The anti-tuberculosis vaccine, Mycobacterium bovis BCG, has been used worldwide, but its protective ...
The memory/activated T cells, which mediate the long-lived host response against tuberculosis, in mi...
DNA vaccine may be a promising tool for controlling tuberculosis development. However, vaccines enco...
Mycobacteria can infect macrophages and dendritic cells (DC), where they reside inside the endosomal...
AbstractTo test the relative efficacy of CD4 and CD8T cells in mediating protective immunity to Myco...
Background. Studies of different vaccine constructs have demonstrated variable efficacy against Myco...
Tuberculosis (TB) is a major health problem of global concern. The control of this disease requires ...
H65, a fusion protein of three pairs of ESX-secreted antigens of Mycobacterium tuberculosis and Myco...
In previous studies, we have described a live recombinant BCG vaccine (rBCG30) overexpressing the 30...